Potential biomarkers of acute cerebral infarction detected by SELDI-TOF-MS

American Journal of Clinical Pathology

Volumn 130, Issue 2, 2008, Pages 299-304

  Zhang, Xiaoping ^a,b   Guo, Tao ^a,b   Wang, Huafang ^a,b   He, Wenjuan ^a,b   Mei, Heng ^a,b   Hong, Mei ^a,b   Yu, Jiekai ^c   Hu, Yu ^a,b   Song, Shanjun ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Key Laboratory of Biological Targeted Therapy of Hubei Province   (China)

^c THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Biomarker; Cerebral infarction; Diagnosis; ProteinChip; SELDI TOF MS; Stroke

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BRAIN INFARCTION; CATION EXCHANGE; CONTROL GROUP; CONTROLLED STUDY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA; PRIORITY JOURNAL; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; CEREBRAL INFARCTION; COMPUTATIONAL BIOLOGY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 48649102532     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/CA242R5VY14HUGE8     Document Type: Article

References (34)

1. Ministry of Health. Chinese Health Statistical Digest 2006. Beijing, China: Ministry of Health, People's Republic of China; 2006(45):1989-2005.
2. Liu M, Wu B, Wang WZ, et al. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol. 2007;6:456-464.
3. Kelly J, Rudd A, Lewis R, et al. Venous thromboembolism after acute stroke. Stroke. 2001;32:262-267.
4. Herrmann M, Vos P, Wunderlich MT, et al. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke. 2000;31:2670-2677.
5. Castillo J, Rodríguez I. Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis. 2004;17(suppl 1):7-18.
6. Silvestri A, Vitale C, Ferretti F, et al. Plasma levels of inflammatory C-reactive protein and interleukin-6 predict outcome in elderly patients with stroke. J Am Geriatr Soc. 2004;52:1586-1587.
7. Smith CJ, Emsley HC, Gavin CM, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004;4:2. doi:10.1186/1471-2377-4-2.
8. Tomitori H, Usui T, Saeki N, et al. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke. 2005;36:2609-2613.
9. Geiger S, Holdenrieder S, Stieber P, et al. Nucleosomes as a new prognostic marker in early cerebral stroke. J Neurol. 2007;254:617-623.
10. Alevizaki M, Synetou M, Xynos K, et al. Low triiodothyronine: a strong predictor of outcome in acute stroke patients. Eur J Clin Invest. 2007;37:651-657.
11. Reynolds MA, Kirchick HJ, Dahlen JR, et al. Early biomarkers of stroke. Clin Chem. 2003;49:1733-1739.
12. Lynch JR, Blessing R, White WD, et al. Novel diagnostic test for acute stroke. Stroke. 2004;35:57-63.
13. Yao XH, Yu HM, Koide SS, et al. Identification of a key protein associated with cerebral ischemia. Brain Res. 2003;967:11-18.
14. Allard L, Lescuyer P, Burgess J, et al. ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke. Proteomics. 2004;4:2242-2251.
15. Chen A, Liao WP, Lu Q, et al. Upregulation of dihydropyrimidinase-related protein 2, spectrin alpha II chain, heat shock cognate protein 70 pseudogene 1 and tropomodulin 2 after focal cerebral ischemia in rats: a proteomics approach. Neurochem Int. 2007;50:1078-1086.
16. Sanchez JC, Lescuyer P, Hochstrasser D, et al. Detection of biomarkers of stroke using SELDI-TOF. Methods Mol Biol. 2007;357:343-350.
17. Zhang X, Hu Y, Hong M, et al. Plasma thrombomodulin, fibrinogen, and activity of tissue factor as risk factors for acute cerebral infarction. Am J Clin Pathol. 2007;128:287-292.
18. Liu Y. Active learning with support vector machine applied to gene expression data for cancer classification. J Chem Inf Comput Sci. 2004;44:1936-1941.
19. Missler U, Wiesmann M, Friedrich C, et al. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke. 1997;28:1956-1960.
20. Zimmermann-Ivol CG, Burkhard PR, Le Floch-Rohr J, et al. Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study. Mol Cell Proteomics. 2004;3:66-72.
21. Dambinova SA, Khounteev GA, Skoromets AA. Multiple panel of biomarkers for TIA/stroke evaluation [letter]. Stroke. 2002;33:1181-1182.
22. Kalafut MA, Schriger DL, Saver JL, et al. Detection of early CT signs of >1/3 middle cerebral artery infarctions: interrater reliability and sensitivity of CT interpretation by physicians involved in acute stroke care. Stroke. 2000;31:1667-1671.
23. Patel SC, Levine SR, Tilley BC, et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA. 2001;286:2830-2838.
24. Wardlaw JM, Lewis SC, Dennis MS, et al. Is visible infarction on computed tomography associated with an adverse prognosis in acute ischemic stroke? Stroke. 1998;29:1315-1319.
25. Lee LJ, Kidwell CS, Alger J, et al. Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke. 2000;31:1081-1089.
26. Floyd JS, Laskowitz DT. A new approach to the diagnosis of acute ischemic stroke: blood-borne biochemical markers. Stroke Clin Updates. 2004;14:1-5.
27. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391-397.
28. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
29. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke. 2003;34:2518-2532.
30. Schroeter M, Zickler P, Denhardt DT, et al. Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice. Brain. 2006;129:1426-1437.
31. Culmsee C, Krieglstein J. Ischaemic brain damage after stroke: new insights into efficient therapeutic strategies. International Symposium on Neurodegeneration and Neuroprotection. EMBO Rep. 2007;8:129-133.
32. Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics. 2004;20:777-785.
33. Seibert V, Ebert MP, Buschmann T. Advances in clinical cancer proteomics: SELDI-TOF-mass spectrometry and biomarker discovery. Brief Funct Genomic Proteomic. 2005;4:16-26.
34. Liotta LA, Lowenthal M, Mehta A, et al. Importance of communication between producers and consumers of publicly available experimental data. J Natl Cancer Inst. 2005;97:310-314.